Literature DB >> 8653786

The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo.

T M DeChiara1, D C Bowen, D M Valenzuela, M V Simmons, W T Poueymirou, S Thomas, E Kinetz, D L Compton, E Rojas, J S Park, C Smith, P S DiStefano, D J Glass, S J Burden, G D Yancopoulos.   

Abstract

Formation of neuromuscular synapses requires a series of inductive interactions between growing motor axons and differentiating muscle cells, culminating in the precise juxtaposition of a highly specialized nerve terminal with a complex molecular structure on the postsynaptic muscle surface. The receptors and signaling pathways mediating these inductive interactions are not known. We have generated mice with a targeted disruption of the gene encoding MuSK, a receptor tyrosine kinase selectively localized to the postsynaptic muscle surface. Neuromuscular synapses do not form in these mice, suggesting a failure in the induction of synapse formation. Together with the results of an accompanying manuscript, our findings indicate that MuSK responds to a critical nerve-derived signal (agrin), and in turn activates signaling cascades responsible for all aspects of synapse formation, including organization of the postsynaptic membrane, synapse-specific transcription, and presynaptic differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8653786     DOI: 10.1016/s0092-8674(00)81251-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  268 in total

1.  Roles of rapsyn and agrin in interaction of postsynaptic proteins with acetylcholine receptors.

Authors:  C Fuhrer; M Gautam; J E Sugiyama; Z W Hall
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

2.  Regulation of neuregulin-mediated acetylcholine receptor synthesis by protein tyrosine phosphatase SHP2.

Authors:  M Tanowitz; J Si; D H Yu; G S Feng; L Mei
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

3.  The Ets transcription factor GABP is required for postsynaptic differentiation in vivo.

Authors:  A Briguet; M A Ruegg
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

4.  Paralytic zebrafish lacking acetylcholine receptors fail to localize rapsyn clusters to the synapse.

Authors:  F Ono; S Higashijima ; A Shcherbatko; J R Fetcho; P Brehm
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

5.  Synapse-forming axons and recombinant agrin induce microprocess formation on myotubes.

Authors:  C S Uhm; B Neuhuber; B Lowe; V Crocker; M P Daniels
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

Review 6.  Clustering of nicotinic acetylcholine receptors: from the neuromuscular junction to interneuronal synapses.

Authors:  Kyung-Hye Huh; Christian Fuhrer
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

7.  Neuregulin expression at neuromuscular synapses is modulated by synaptic activity and neurotrophic factors.

Authors:  Jeffrey A Loeb; Abdelkrim Hmadcha; Gerald D Fischbach; Susan J Land; Vaagn L Zakarian
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

8.  Motoneuron survival is enhanced in the absence of neuromuscular junction formation in embryos.

Authors:  J Terrado; R W Burgess; T DeChiara; G Yancopoulos; J R Sanes; A C Kato
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

9.  Src-class kinases act within the agrin/MuSK pathway to regulate acetylcholine receptor phosphorylation, cytoskeletal anchoring, and clustering.

Authors:  A S Mohamed; K A Rivas-Plata; J R Kraas; S M Saleh; S L Swope
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

10.  Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis.

Authors:  Isabell Cordts; Nicolas Bodart; Kathi Hartmann; Katerina Karagiorgou; John S Tzartos; Lin Mei; Jens Reimann; Philip Van Damme; Michael H Rivner; Alain Vigneron; Joachim Weis; Jörg B Schulz; Socrates J Tzartos; Kristl G Claeys
Journal:  J Neurol       Date:  2017-05-17       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.